Suppr超能文献

普萘洛尔在甲状腺次全切除治疗甲状腺毒症中的应用

Propranolol in the treatment of thyrotoxicosis by subtotal thyroidectomy.

作者信息

Toft A D, Irvine W J, McIntosh D, MacLeod D A, Seth J, Cameron E H, Lidgard G P

出版信息

J Clin Endocrinol Metab. 1976 Dec;43(6):1312-6. doi: 10.1210/jcem-43-6-1312.

Abstract

Subtotal thyroidectomy was performed in 40 patients with thyrotoxicosis in whom propranolol alone was used as preparation for surgery. Propranolol was given orally in a dose of 40 mg every 6 h for a mean preoperative period of 17 days (range 4-60 days) and continued for seven days after operation. The mean +/- SE blood loss at operation was only 160 +/- 20 ml. The period of follow-up was from three to nine months. Recurrent thyrotoxicosis has not occurred in any patient. Low levels of total serum triiodothyronine (T3) and total serum thyroxine (T4) were observed in the early postoperative weeks in some patients and were associated with symptoms of mild hypothyroidism, but by six months in the presence of a raised serum thyrotropin (TSH) the thyroid hormone levels returned to normal. Permanent hypothyroidism developed in only two patients. Despite normal or low total serum T3 and T4 levels, the TSH response to thyrotropin-releasing hormone (TRH) was absent in all patients one week after operation. At four weeks and at eight weeks, the response was absent or sub-normal in 70% and 20% of the patients respectively, indicating a delay in the recovery of the hypothalamo-pituitary axis previously exposed to high levels of T3 and T4. It is considered that subtotal thyroidectomy for thyrotoxicosis in patients prepared with propranolol is an acceptable procedure which has some advantages over the conventional preparation with carbimazole and potassium iodide, not the least of which are the potential reduction in preparation time, the more flexible timing of operation, and the reduced operative blood loss.

摘要

对40例甲状腺毒症患者实施了甲状腺次全切除术,这些患者仅使用普萘洛尔作为手术准备。普萘洛尔口服给药,剂量为每6小时40mg,术前平均用药17天(范围4 - 60天),术后持续用药7天。手术时平均±标准误失血量仅为160±20ml。随访期为3至9个月。所有患者均未出现复发性甲状腺毒症。部分患者术后早期血清总三碘甲状腺原氨酸(T3)和总甲状腺素(T4)水平较低,并伴有轻度甲状腺功能减退症状,但到6个月时,随着血清促甲状腺激素(TSH)升高,甲状腺激素水平恢复正常。仅2例患者发生永久性甲状腺功能减退。尽管血清总T3和T4水平正常或偏低,但术后1周所有患者促甲状腺激素释放激素(TRH)刺激试验时促甲状腺激素(TSH)无反应。术后4周和8周时,分别有70%和20%的患者反应缺失或低于正常,表明先前暴露于高水平T3和T4的下丘脑 - 垂体轴恢复延迟。认为对用普萘洛尔准备的甲状腺毒症患者实施甲状腺次全切除术是一种可接受的手术方法,与传统的卡比马唑和碘化钾准备相比有一些优点,其中最重要的是可能缩短准备时间、手术时机更灵活以及减少术中失血量。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验